Literature DB >> 25530845

Improving the design of the agarose spot assay for eukaryotic cell chemotaxis.

Alex C Szatmary1, Christina H Stuelten2, Ralph Nossal3.   

Abstract

Migration of cells along gradients of effector molecules, i.e., chemotaxis, is necessary in immune response and is involved in development and cancer metastasis. The experimental assessment of chemotaxis thus is of high interest. The agarose spot assay is a simple tissue culture system used to analyze chemotaxis. Although direction sensing requires gradients to be sufficiently steep, how the chemical gradients developed in this assay change over time, and thus, under what conditions chemotaxis is plausible, has not yet been determined. Here, we use numerical solution of the diffusion equation to determine the chemoattractant gradient produced in the assay. Our analysis shows that, for the usual spot size, the lifetime of the assay is optimized if the chemoattractant concentration in the spot is initially 30 times the dissociation constant of the chemoattractant-receptor bond. This result holds regardless of the properties of the chemoattractant. With this initial concentration, the chemoattractant gradient falls to the minimum threshold for directional sensing at the same time that the concentration drops to the optimal level for detecting gradient direction. If a higher initial chemoattractant concentration is used, the useful lifetime of the assay is likely to be shortened because receptor saturation may decrease the cells' sensitivity to the gradient; lower initial concentrations would result in too little chemoattractant for the cells to detect. Moreover, chemoattractants with higher diffusion coefficients would sustain gradients for less time. Based on previous measurements of the diffusion coefficients of the chemoattractants EGF and CXCL12, we estimate that the assay will produce gradients that cells can sense for a duration of 10 h for EGF and 5 h for CXCL12. These gradient durations are comparable to what can be achieved with the Boyden chamber assay. The analysis presented in this work facilitates determination of suitable parameters for the assay, and can be used to assess whether observed cell motility is likely due to chemotaxis or chemokinesis.

Entities:  

Year:  2014        PMID: 25530845      PMCID: PMC4266135          DOI: 10.1039/C4RA08572H

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  40 in total

Review 1.  Chemotaxis: signalling the way forward.

Authors:  Peter J M Van Haastert; Peter N Devreotes
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

Review 2.  Recent developments in microfluidics-based chemotaxis studies.

Authors:  Jiandong Wu; Xun Wu; Francis Lin
Journal:  Lab Chip       Date:  2013-05-28       Impact factor: 6.799

3.  Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.

Authors:  Carol Sawyer; Justin Sturge; Dorothy C Bennett; Michael J O'Hare; William E Allen; Jennifer Bain; Gareth E Jones; Bart Vanhaesebroeck
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

4.  Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.

Authors:  R B Lichtner; A Menrad; A Sommer; U Klar; M R Schneider
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

5.  A comparison of the migration patterns of normal and malignant cells in two assay systems.

Authors:  J Varani; W Orr; P A Ward
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

6.  Asymmetric modulation of cytosolic cAMP activity induces growth cone turning.

Authors:  A M Lohof; M Quillan; Y Dan; M M Poo
Journal:  J Neurosci       Date:  1992-04       Impact factor: 6.167

7.  Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages.

Authors:  M Di Rosa; G Malaguarnera; C De Gregorio; M Palumbo; G Nunnari; L Malaguarnera
Journal:  Cell Immunol       Date:  2012-11-29       Impact factor: 4.868

8.  Chemotactic reorientation of granulocytes stimulated with micropipettes containing fMet-Leu-Phe.

Authors:  G Gerisch; H U Keller
Journal:  J Cell Sci       Date:  1981-12       Impact factor: 5.285

9.  Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.

Authors:  Sanaa Al Saleh; Fahd Al Mulla; Yunus A Luqmani
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

10.  Quantitative analysis of cell motility and chemotaxis in Dictyostelium discoideum by using an image processing system and a novel chemotaxis chamber providing stationary chemical gradients.

Authors:  P R Fisher; R Merkl; G Gerisch
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

View more
  4 in total

1.  Determining whether observed eukaryotic cell migration indicates chemotactic responsiveness or random chemokinetic motion.

Authors:  A C Szatmary; R Nossal
Journal:  J Theor Biol       Date:  2017-05-10       Impact factor: 2.691

2.  Modeling neutrophil migration in dynamic chemoattractant gradients: assessing the role of exosomes during signal relay.

Authors:  Alex C Szatmary; Ralph Nossal; Carole A Parent; Ritankar Majumdar
Journal:  Mol Biol Cell       Date:  2017-09-27       Impact factor: 4.138

3.  Multiscale modeling of collective cell migration elucidates the mechanism underlying tumor-stromal interactions in different spatiotemporal scales.

Authors:  Zarifeh Heidary; Shaghayegh Haghjooy Javanmard; Iman Izadi; Nasrin Zare; Jafar Ghaisari
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

4.  Agarose Spot as a Comparative Method for in situ Analysis of Simultaneous Chemotactic Responses to Multiple Chemokines.

Authors:  Mohaned Ahmed; Haneen A Basheer; Jose M Ayuso; Djevdet Ahmet; Marco Mazzini; Roshan Patel; Steven D Shnyder; Victoria Vinader; Kamyar Afarinkia
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.